|
| |||||
 | ||||||
Cardiovascular
| ||||||
Most Read Stories This Week | CME SPOTLIGHT |
| Reducing Cardiovascular Complications of Chronic Kidney Disease: New Prospectives in Improving Patient Outcomes This activity focuses on preventing complications in CKD including CV mortality, improving patient outcomes and weighing the benefits of lipid management therapy in these patients. Source: National Kidney Foundation [more] Individualizing Diabetes Treatment For Improved Glycemic Control and Management of Comorbidities Focusing on individualizing diabetes treatment, this webcast activity provides the opportunity to learn about the latest advances and critical issues in glycemic control and management from faculty who are at the forefront of diabetes management. Source: The Endocrine Society [more] The Atrial Fibrillation Revolution: Refining the Evidence-Based Approach to Stroke Prevention Atrial fibrillation-related stroke causes significant morbidity and mortality and is a growing major public health burden. This CME activity educates on effective arrhythmia management and cardioembolic stroke prevention. Source: Applied Clinical Education [more] |
| CME SPOTLIGHT |
| Performance Improvement Strategies in Diabetes Care Participate in this complimentary, certified Diabetes PI CME activity which is approved through the American Board of Internal Medicine's (ABIM) Approved Quality Improvement (AQI) Pathway and is eligible for 20 points towards the Self-Evaluation of Practice Performance requirement of Maintenance of Certification (MOC). Source: Med-IQ and The Endocrine Society [more] CODE RED: Cardiometabolic Disease This CME survey addresses system, patient, and provider barriers to optimal care of patients with cardiometabolic risk factors. Your answers will establish rationales for ongoing performance-improvement educational programs. Source: Applied Clinical Education [more] Build A Case in Type 2 Diabetes: Your Patients and GLP-1 Receptor Agonist Therapy This activity is intended to teach family physicians about aspects of glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, such as distinguishing characteristics of available agents; anticipated efficacy, tolerability, and safety; and approaches to overcoming treatment-related barriers. Source: The Institute for Medical and Nursing Education (IMNE) [more] |
  iPhone/iPod Touch  Install it today |
www.medpagetoday.com, with the email address: kostikblog@ukr.net.
Change ALL email settings
Instant Unsubscribe from "Weekly Top Stories: Cardiovascular Edition"
TECHNICAL QUESTIONS:
webmaster@medpagetoday.com
MedPage Today, LLC. - Overlook at Great Notch - 150 Clove Road - Little Falls, New Jersey 07424 - Tel: (973) 890-0985 - Fax: (973) 890-1327
